Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M-Y Lee

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Parkinsonism & Related Disorders|May 2, 2001
Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brainJ Q. Trojanowski, V M.-Y. Lee
Neurology|September 8, 2010
Distinct cerebral perfusion patterns in FTLD and ADW T Hu, Z Wang, V M-Y Lee, et al.
Current Topics in Medicinal Chemistry|February 16, 2011
Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathiesC Ballatore, K R Brunden, J Q Trojanowski, et al.
Neuro-Signals|December 22, 2007
Biomarkers for early detection of Alzheimer pathologyC M Clark, C Davatzikos, A Borthakur, et al.
Neuroscience|June 5, 2002
Non-classical nuclear localization signal peptides for high efficiency lipofection of primary neurons and neuronal cell linesH Ma, J Zhu, M Maronski, et al.
Neurology|August 18, 2010
Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasiaW T Hu, C McMillan, D Libon, et al.
Neurology|August 27, 2003
Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementiaY Yao, V Zhukareva, S Sung, et al.
Neurology|March 7, 2007
Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosisM S Forman, E J Mufson, S Leurgans, et al.
Neurology|June 23, 2006
Glucocerebrosidase mutations are an important risk factor for Lewy body disordersO Goker-Alpan, B I Giasson, M J Eblan, et al.
Neuropathology and Applied Neurobiology|October 15, 2010
TDP-43 pathology occurs infrequently in multiple system atrophyF Geser, J A Malunda, H I Hurtig, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Parkinsonism & Related Disorders|May 2, 2001
Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brainJ Q. Trojanowski, V M.-Y. Lee
Neurology|September 8, 2010
Distinct cerebral perfusion patterns in FTLD and ADW T Hu, Z Wang, V M-Y Lee, et al.
Current Topics in Medicinal Chemistry|February 16, 2011
Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathiesC Ballatore, K R Brunden, J Q Trojanowski, et al.
Neuro-Signals|December 22, 2007
Biomarkers for early detection of Alzheimer pathologyC M Clark, C Davatzikos, A Borthakur, et al.
Neuroscience|June 5, 2002
Non-classical nuclear localization signal peptides for high efficiency lipofection of primary neurons and neuronal cell linesH Ma, J Zhu, M Maronski, et al.
Neurology|August 18, 2010
Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasiaW T Hu, C McMillan, D Libon, et al.
Neurology|August 27, 2003
Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementiaY Yao, V Zhukareva, S Sung, et al.
Neurology|March 7, 2007
Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosisM S Forman, E J Mufson, S Leurgans, et al.
Neurology|June 23, 2006
Glucocerebrosidase mutations are an important risk factor for Lewy body disordersO Goker-Alpan, B I Giasson, M J Eblan, et al.
Neuropathology and Applied Neurobiology|October 15, 2010
TDP-43 pathology occurs infrequently in multiple system atrophyF Geser, J A Malunda, H I Hurtig, et al.
Pageof 3